Strides Pharma shares decline 5% after Q1; profit rises 58%, margins contract
Shares of Strides Pharma Science Ltd. fell more than 5% on Friday, July 31, even after the company reported a strong rise in June quarter earnings. The drugmaker posted a 57.5% YoY increase in net profit to ₹157 crore, compared with ₹100 crore a year earlier. Revenue rose 13% YoY to ₹1,265.4 crore from ₹1,119.7…
